30 JANUARY

NEW ZEALAND GAZETTE

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference
to a medicine applies:

(i) if the medicine is in an injection or eye preparation,
to any concentration of that medicine; and

(ii) if the medicine is not in an injection or eye
preparation, only if the concentration of the medicine
or the concentration of the total active principles of
the medicine is greater than 10 milligrams per litre
or per kilogram.

Where any reference is modified by a statement of the
strength of the medicine, the strength is calculated using
the free acid, base, alcohol or element unless specifically
stated otherwise.

Schedule 1
Prescription Medicines

Acepromazine

Adenosine; for injection

Amethocaine; for internal use; for external use in medicines
containing more than 10%; for ophthalmic use except
when used in practice by a registered optometrist

Amylocaine

Aristolochic acid; at all strengths

Atomoxetine

Atropa belladonna; except when specified elsewhere in the
Schedule

Atropine; except when specified elsewhere in the Schedule;
except when used as an antidote in a device designed
for self-injection; except in medicines containing 100
micrograms or less per litre or per kilogram

Atropine methonitrate

Benorylate

Benzocaine; for internal use; for external use in medicines
containing more than 10%

Benzydamine; for internal use

Bexarotene

Butacaine

Butyl aminobenzoate; except in medicines for dermal use
containing 2% or less

Cinchocaine; for ophthalmic use; for external use in
medicines containing more than 0.5%

Clindamycin

Colestyramine

Darbepoetin

Datura spp; except for oral use when specified elsewhere in
the Schedule; except in datura stramonium or datura
tatula for smoking or burning

Dextrorphan

Dicyclomine

Digoxin-specific antibody fragment

Diperodon

Drotrecogin

Duboisia leichhardtii; except when specified elsewhere in
the Schedule

Duboisia myoporides; except when specified elsewhere in
the Schedule

Etidocaine

Ezetimibe

Folic acid; for injection

Folinic acid; for injection

Glatiramer acetate

Guaiphenesin; except for oral use in medicines containing
2% or less or 200 milligrams or less

253

Homatropine

Hyoscine; except when specified elsewhere in the Schedule

Hyoscine butylbromide; except when specified elsewhere in
the Schedule

Hyoscyamine; except when specified elsewhere in the
Schedule

Hyoscyamus niger; except when specified elsewhere in the
Schedule

Hypromellose; for injection

Insulins

Levetiracetam

Levosimendan

Lignocaine; for oral use except in throat lozenges containing
30 milligrams or less per dose form; for ophthalmic use
except when used in practice by a registered optometrist;
for injection except when used as a local anaesthetic in
practice by a registered nurse or podiatrist or by a dental
therapist; for external use in medicines containing more
than 10%

Nicoumalone

Nitrofurazone

Nux vomica

Podophyllum emodi; for internal use; for external use for the
treatment of anogenital warts; for other external use in
medicines containing more than 20% of podophyllin

Podophyllum peltatum; for internal use; for external use for
the treatment of anogenital warts; for other external use
in medicines containing more than 20% of podophyllin

Podophyllotoxin; for internal use; for external use for the
treatment of anogenital warts; for other external use in
medicines containing more than 1%

Pramocaine

Pregnenolone

Prilocaine; for injection except when used as a local
anaesthetic by a dental therapist; except when specified
elsewhere in the Schedule

Propantheline

Protamine sulfate

Quinisocaine

Sabadilla; except when specified elsewhere in the Schedule

Strychnos spp

Thiomesterone

Vardenafil

Schedule 2
Restricted Medicines

Erythryl tetranitrate

Hyoscine butylbromide; for oral use in medicines containing
not more than 10 milligrams per dose form and in packs
containing not more than 20 tablets or capsules

Mannityl hexanitrate

Podophyllum emodi; for external use for the treatment of
warts other than anogenital warts in medicines containing
20% or less and more than 10% of podophyllin

Podophyllum peltatum; for external use for the treatment of
warts other than anogenital warts in medicines containing
20% or less and more than 10% of podophyllin

Podophyllotoxin; for external use for the treatment of warts
other than anogenital warts in medicines containing 1% or
less and more than 0.5%

Prochlorperazine; in packs containing not more than
10 tablets for the treatment of nausea associated with
migraine or, when sold by pharmacists or nurses
accredited to sell levonorgestrel for emergency